Topical tazarotene did not improve response to imiquimod 5% in lentigo maligna

ALBUQUERQUE – Adding topical tazarotene did not improve response to 5% imiquimod in lentigo maligna, based on data from nearly 300 patients.

But patients with higher levels of inflammation in...